Thomas Brunner
Papers
1
Total Citations
152
H-Index
1
About
Thomas Brunner is a leading figure in radiation oncology, with a primary research focus on stereotactic body radiotherapy (SBRT) for oligometastatic disease. His major contributions center on establishing evidence-based patterns of care and outcome analyses for SBRT, particularly for liver metastases. His landmark study, "The SBRT database initiative of the German Society for Radiation Oncology (DEGRO)," analyzed data from 474 patients with 623 liver oligometastases, providing critical insights into treatment efficacy and prognostic factors. This work, with 152 citations, has helped standardize SBRT practice and improve patient selection. Brunner's research has been instrumental in demonstrating that SBRT can achieve high local control rates with minimal toxicity, offering a non-invasive alternative for patients with limited metastatic spread. His leadership in the DEGRO initiative underscores his role in shaping national treatment guidelines. With a career dedicated to advancing precision radiotherapy, Brunner's work continues to influence clinical decision-making and inspire further investigation into the role of SBRT in managing oligometastatic cancers.
Research Focus
Key Achievements
Top Papers
- 1